{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:12:45Z","timestamp":1789956765305,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The involvement of HOXA4 in colorectal cancer and epithelial ovarian cancer has been reported. Although it has been reported that the\n                    <jats:italic>Hoxa4<\/jats:italic>\n                    gene is involved in the patterning of the mouse lung during embryonic development, little is known about the biological functions of HOXA4 in lung cancer. In the current study, HOXA4 expression was down-regulated in lung cancer tissues when compared with non-cancerous tissues. HOXA4 expression was associated with tumor size, TNM stage, lymph node metastasis and prognosis. Bioinformatics analysis revealed that HOXA4 expression was negatively correlated with cell cycle, metastasis, and the Wnt signaling pathway. Moreover, HOXA4 overexpression in lung cancer cell lines suppressed cell proliferation, migration, and invasion. HOXA4 decreased the protein expression levels of \u03b2-catenin, Cyclin D1, c-Myc and Survivin, indicating the inhibition of Wnt signaling. HOXA4 significantly increased the protein and mRNA levels of glycogen synthase kinase-3\u03b2 (GSK3\u03b2) by promoting its transcription. Furthermore, inhibition of GSK3\u03b2 by LiCl abolished the suppression of cell growth, migration, and invasion mediated by HOXA4. Overexpression of HOXA4 in xenograft tumors also decreased tumor growth and Wnt signaling. Collectively, these data suggest that HOXA4 is a potential diagnostic and prognostic marker in lung cancer, and its overexpression could inhibit lung cancer progression in part by promoting GSK3\u03b2 transcription.\n                  <\/jats:p>","DOI":"10.1038\/s41419-018-0497-x","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T06:52:14Z","timestamp":1524466334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Shaofei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"497_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"497_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/07357900601130748","volume":"25","author":"GS Longo-Sorbello","year":"2007","unstructured":"Longo-Sorbello, G. S., Chen, B., Budak-Alpdogan, T. & Bertino, J. R. Role of pemetrexed in non-small cell lung cancer. Cancer Invest. 25, 59\u201366 (2007).","journal-title":"Cancer Invest."},{"key":"497_CR3","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch, F. R. et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol. 21, 3798\u20133807 (2003).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 4","key":"497_CR4","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37","author":"RI Nicholson","year":"2001","unstructured":"Nicholson, R. I., Gee, J. M. & Harper, M. E. EGFR and cancer prognosis. Eur. J. Cancer 37(Suppl 4), S9\u2013S15 (2001).","journal-title":"Eur. J. Cancer"},{"key":"497_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W","volume":"188","author":"E Brambilla","year":"1999","unstructured":"Brambilla, E., Moro, D., Gazzeri, S. & Brambilla, C. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J. Pathol. 188, 351\u2013360 (1999).","journal-title":"J. Pathol."},{"key":"497_CR6","doi-asserted-by":"publisher","first-page":"djt356","DOI":"10.1093\/jnci\/djt356","volume":"106","author":"DJ Stewart","year":"2014","unstructured":"Stewart, D. J. Wnt signaling pathway in non-small cell lung cancer. J. Natl Cancer Inst. 106, djt356 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"497_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1101\/sqb.2005.70.043","volume":"70","author":"D Haber","year":"2005","unstructured":"Haber, D. et al. Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors. Cold Spring Harb Symp Quant Biol 70, 419\u2013426 (2005).","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"497_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/resp.12490","volume":"20","author":"NB Kumarakulasinghe","year":"2015","unstructured":"Kumarakulasinghe, N. B., van Zanwijk, N. & Soo, R. A. Molecular targeted therapy in the treatment of advanced stage non\u2010small cell lung cancer (NSCLC). Respirology 20, 370\u2013378 (2015).","journal-title":"Respirology"},{"key":"497_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0092-8674(94)90290-9","volume":"78","author":"R Krumlauf","year":"1994","unstructured":"Krumlauf, R. Hox genes in vertebrate development. Cell 78, 191\u2013201 (1994).","journal-title":"Cell"},{"key":"497_CR10","doi-asserted-by":"publisher","first-page":"R676","DOI":"10.1016\/S0960-9822(98)70433-6","volume":"8","author":"M Akam","year":"1998","unstructured":"Akam, M. Hox genes: from master genes to micromanagers. Curr. Biol. 8, R676\u2013R678 (1998).","journal-title":"Curr. Biol."},{"key":"497_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1242\/dev.107.2.343","volume":"107","author":"B Galliot","year":"1989","unstructured":"Galliot, B. et al. The mouse Hox-1.4 gene: primary structure, evidence for promoter activity and expression during development. Development 107, 343\u2013359 (1989).","journal-title":"Development"},{"key":"497_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1242\/dev.117.3.823","volume":"117","author":"RR Behringer","year":"1993","unstructured":"Behringer, R. R. et al. Sequences 5\u2032 of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development. Development 117, 823\u2013833 (1993).","journal-title":"Development"},{"key":"497_CR13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1242\/dev.125.11.1991","volume":"125","author":"AI Packer","year":"1998","unstructured":"Packer, A. I., Crotty, D. A., Elwell, V. A. & Wolgemuth, D. J. Expression of the murine Hoxa4 gene requires both autoregulation and a conserved retinoic acid response element. Development 125, 1991\u20131998 (1998).","journal-title":"Development"},{"key":"497_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U","volume":"217","author":"AI Packer","year":"2000","unstructured":"Packer, A. I., Mailutha, K. G., Ambrozewicz, L. A. & Wolgemuth, D. J. Regulation of the Hoxa4 and Hoxa5 genes in the embryonic mouse lung by retinoic acid and TGFbeta1: implications for lung development and patterning. Dev. Dyn. 217, 62\u201374 (2000).","journal-title":"Dev. Dyn."},{"key":"497_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/scd.2013.0039","volume":"23","author":"S Bhatlekar","year":"2014","unstructured":"Bhatlekar, S. et al. Identification of a developmental gene expression signature, including HOX genes, for the normal human colonic crypt stem cell niche: overexpression of the signature parallels stem cell overpopulation during colon tumorigenesis. Stem. Cells Dev. 23, 167\u2013179 (2014).","journal-title":"Stem. Cells Dev."},{"key":"497_CR16","first-page":"931","volume":"28","author":"T Yamashita","year":"2006","unstructured":"Yamashita, T. et al. Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells. Int. J. Oncol. 28, 931\u2013938 (2006).","journal-title":"Int. J. Oncol."},{"key":"497_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1158\/1541-7786.MCR-08-0466","volume":"7","author":"C Klausen","year":"2009","unstructured":"Klausen, C., Leung, P. C. & Auersperg, N. Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin. Mol. Cancer Res. 7, 1425\u20131437 (2009).","journal-title":"Mol. Cancer Res."},{"key":"497_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/sj.bjc.6604857","volume":"100","author":"L Plowright","year":"2009","unstructured":"Plowright, L., Harrington, K., Pandha, H. & Morgan, R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br. J. Cancer 100, 470 (2009).","journal-title":"Br. J. Cancer"},{"key":"497_CR19","first-page":"797","volume":"15","author":"M Abe","year":"2006","unstructured":"Abe, M. et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol. Rep. 15, 797\u2013802 (2006).","journal-title":"Oncol. Rep."},{"key":"497_CR20","doi-asserted-by":"publisher","first-page":"a008052","DOI":"10.1101\/cshperspect.a008052","volume":"4","author":"P Polakis","year":"2012","unstructured":"Polakis, P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 4, a008052 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"497_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00432-010-0934-4","volume":"137","author":"C Li","year":"2011","unstructured":"Li, C. et al. Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. J. Cancer Res. Clin. Oncol. 137, 771\u2013778 (2011).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"497_CR22","doi-asserted-by":"crossref","unstructured":"Stewart D. J. Wnt signaling pathway in non-small cell lung cancer. J. Natl Cancer Inst. 106, djt356 (2014).","DOI":"10.1093\/jnci\/djt356"},{"key":"497_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2015.11.001","volume":"28","author":"P Ord\u00f3\u00f1ez-Mor\u00e1n","year":"2015","unstructured":"Ord\u00f3\u00f1ez-Mor\u00e1n, P., Dafflon, C., Imajo, M., Nishida, E. & Huelsken, J. HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer. Cancer Cell. 28, 815\u2013829 (2015).","journal-title":"Cancer Cell."},{"key":"497_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1634\/stemcells.2004-0198","volume":"23","author":"CM Ferrell","year":"2005","unstructured":"Ferrell, C. M. et al. Activation of stem\u2010cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells. Stem Cells 23, 644\u2013655 (2005).","journal-title":"Stem Cells"},{"key":"497_CR25","first-page":"4789","volume":"6","author":"S Kase","year":"2000","unstructured":"Kase, S. et al. Expression of E-cadherin and \u03b2-catenin in human non-small cell lung cancer and the clinical significance. Clin. Cancer Res 6, 4789\u20134796 (2000).","journal-title":"Clin. Cancer Res"},{"key":"497_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2006.09.024","volume":"55","author":"O Gautschi","year":"2007","unstructured":"Gautschi, O., Ratschiller, D., Gugger, M., Betticher, D. C. & Heighway, J. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55, 1\u201314 (2007).","journal-title":"Lung Cancer"},{"key":"497_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/bjc.1996.52","volume":"73","author":"DC Betticher","year":"1996","unstructured":"Betticher, D. C. et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer 73, 294 (1996).","journal-title":"Br. J. Cancer"},{"key":"497_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1756-9966-29-151","volume":"29","author":"Z Chen","year":"2010","unstructured":"Chen, Z. et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J. Exp. Clin. Cancer Res. 29, 151 (2010).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"497_CR29","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-04-1681","volume":"64","author":"K Krysan","year":"2004","unstructured":"Krysan, K., Dalwadi, H., Sharma, S., P\u00f5ld, M. & Dubinett, S. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 64, 6359\u20136362 (2004).","journal-title":"Cancer Res."},{"key":"497_CR30","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1158\/0008-5472.CAN-06-1788","volume":"67","author":"Q Ding","year":"2007","unstructured":"Ding, Q. et al. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3\u03b2 activity and associates with poor prognosis in human breast cancer. Cancer Res. 67, 4564\u20134571 (2007).","journal-title":"Cancer Res."},{"key":"497_CR31","doi-asserted-by":"publisher","first-page":"7756","DOI":"10.1158\/0008-5472.CAN-06-4665","volume":"67","author":"C Ma","year":"2007","unstructured":"Ma, C. et al. The role of glycogen synthase kinase 3\u03b2 in the transformation of epidermal cells. Cancer Res. 67, 7756\u20137764 (2007).","journal-title":"Cancer Res."},{"key":"497_CR32","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1158\/0008-5472.CAN-05-1021","volume":"65","author":"M Farago","year":"2005","unstructured":"Farago, M. et al. Kinase-inactive glycogen synthase kinase 3\u03b2 promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 65, 5792\u20135801 (2005).","journal-title":"Cancer Res."},{"key":"497_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/cr.2007.14","volume":"17","author":"Y Wang","year":"2007","unstructured":"Wang, Y., Lam, K. S. & Xu, A. Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Res. 17, 280\u2013282 (2007).","journal-title":"Cell Res."},{"key":"497_CR34","first-page":"3561","volume":"27","author":"H Zheng","year":"2007","unstructured":"Zheng, H., Saito, H., Masuda, S., Yang, X. & Takano, Y. Phosphorylated GSK3\u03b2-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res. 27, 3561\u20133569 (2007).","journal-title":"Anticancer Res."},{"key":"497_CR35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4161\/cc.4.6.1744","volume":"4","author":"BP Zhou","year":"2005","unstructured":"Zhou, B. P. & Hung, M.-C. Wnt, hedgehog, and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis. Cell Cycle 4, 772\u2013776 (2005).","journal-title":"Cell Cycle"},{"key":"497_CR36","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/ncb1508","volume":"8","author":"JI Yook","year":"2006","unstructured":"Yook, J. I. et al. A Wnt\u2013Axin2\u2013GSK3\u03b2 cascade regulates Snail1 activity in breast cancer cells. Nat. Cell. Biol. 8, 1398\u20131406 (2006).","journal-title":"Nat. Cell. Biol."},{"key":"497_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.bbrc.2005.07.041","volume":"334","author":"A Shakoori","year":"2005","unstructured":"Shakoori, A. et al. Deregulated GSK3\u03b2 activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem. Biophys. Res. Commun. 334, 1365\u20131373 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"497_CR38","doi-asserted-by":"publisher","first-page":"e91231","DOI":"10.1371\/journal.pone.0091231","volume":"9","author":"J Zeng","year":"2014","unstructured":"Zeng, J. et al. GSK3\u03b2 overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells. PLoS ONE 9, e91231 (2014).","journal-title":"PLoS ONE"},{"key":"497_CR39","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-04-3642","volume":"65","author":"AV Ougolkov","year":"2005","unstructured":"Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A. & Billadeau, D. D. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 65, 2076\u20132081 (2005).","journal-title":"Cancer Res."},{"key":"497_CR40","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-10-0275","volume":"16","author":"S Naito","year":"2010","unstructured":"Naito, S. et al. Glycogen synthase kinase-3\u03b2: a prognostic marker and a potential therapeutic target in human bladder cancer. Clin. Cancer Res. 16, 5124\u20135132 (2010).","journal-title":"Clin. Cancer Res."},{"key":"497_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.cr.7310078","volume":"16","author":"Q Cao","year":"2006","unstructured":"Cao, Q., Lu, X. & Feng, Y.-J. Glycogen synthase kinase-3\u03b2 positively regulates the proliferation of human ovarian cancer cells. Cell Res. 16, 671\u2013677 (2006).","journal-title":"Cell Res."},{"key":"497_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"497_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"497_CR44","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1096\/fj.03-0106fje","volume":"17","author":"HS Kim","year":"2003","unstructured":"Kim, H.-S. et al. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3\u03b2 expression. FASEB J. 17, 1951\u20131953 (2003).","journal-title":"FASEB J."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0497-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:54:41Z","timestamp":1671519281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0497-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"465"}}